[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

DK1026167T3 - Tricykliske triazolobenzazepinderivater, fremgangsmåde til fremstilling af disse samt antiallergiske midler - Google Patents

Tricykliske triazolobenzazepinderivater, fremgangsmåde til fremstilling af disse samt antiallergiske midler

Info

Publication number
DK1026167T3
DK1026167T3 DK98944289T DK98944289T DK1026167T3 DK 1026167 T3 DK1026167 T3 DK 1026167T3 DK 98944289 T DK98944289 T DK 98944289T DK 98944289 T DK98944289 T DK 98944289T DK 1026167 T3 DK1026167 T3 DK 1026167T3
Authority
DK
Denmark
Prior art keywords
antiallergic agents
preparation
alkyl
chem
alkoxy
Prior art date
Application number
DK98944289T
Other languages
Danish (da)
English (en)
Inventor
Yasuo Ohtsuka
Toshio Nishizuka
Sohjiro Shiokawa
Seiji Tsutsumi
Mami Kawaguchi
Hideo Kitagawa
Hiromi Takata
T Shishikura
T Ishikura
Kenichi Fushihara
Yumiko Okada
Sachiko Miyamoto
Maki Shiobara
Original Assignee
Meiji Seika Kaisha
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meiji Seika Kaisha filed Critical Meiji Seika Kaisha
Application granted granted Critical
Publication of DK1026167T3 publication Critical patent/DK1026167T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40Unsaturated compounds
    • C07C59/76Unsaturated compounds containing keto groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/738Esters of keto-carboxylic acids or aldehydo-carboxylic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/041,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK98944289T 1997-09-29 1998-09-29 Tricykliske triazolobenzazepinderivater, fremgangsmåde til fremstilling af disse samt antiallergiske midler DK1026167T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP26461197 1997-09-29
JP5206398 1998-03-04
PCT/JP1998/004363 WO1999016770A1 (fr) 1997-09-29 1998-09-29 Derives de triazolobenzazepine tricyclique, leur procede de production et antiallergique

Publications (1)

Publication Number Publication Date
DK1026167T3 true DK1026167T3 (da) 2003-05-26

Family

ID=26392670

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98944289T DK1026167T3 (da) 1997-09-29 1998-09-29 Tricykliske triazolobenzazepinderivater, fremgangsmåde til fremstilling af disse samt antiallergiske midler

Country Status (25)

Country Link
US (3) US6372735B1 (fr)
EP (1) EP1026167B1 (fr)
JP (1) JP3188482B2 (fr)
KR (1) KR100389140B1 (fr)
CN (2) CN1312135C (fr)
AT (1) ATE233764T1 (fr)
AU (1) AU744636B2 (fr)
BR (1) BR9814055B1 (fr)
CA (1) CA2305307C (fr)
DE (1) DE69811930T2 (fr)
DK (1) DK1026167T3 (fr)
ES (1) ES2191963T3 (fr)
HK (1) HK1032782A1 (fr)
HU (1) HUP0004020A3 (fr)
ID (1) ID24101A (fr)
IL (1) IL135303A0 (fr)
NO (2) NO319542B1 (fr)
NZ (1) NZ503601A (fr)
PL (1) PL339544A1 (fr)
PT (1) PT1026167E (fr)
RU (1) RU2198885C2 (fr)
SK (1) SK283869B6 (fr)
TR (1) TR200000808T2 (fr)
TW (1) TW510902B (fr)
WO (1) WO1999016770A1 (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2346858T3 (es) * 2001-12-26 2010-10-21 Meiji Seika Kaisha Ltd. Sustancia amorfa de un derivado triciclico de triazolobenzazepina.
ES2283781T3 (es) * 2002-02-01 2007-11-01 Meiji Seika Kaisha, Ltd. Procedimiento para producir un compuesto de 1,2,3-triazol.
RS20050002A (en) 2002-07-09 2007-09-21 Bristol Myers Squibb Company, Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method
JP4579681B2 (ja) 2002-07-09 2010-11-10 ブリストル−マイヤーズ スクイブ カンパニー 抗糖尿病薬および抗肥満薬として有用な置換ヘテロシクロ誘導体および方法
EP1642900A1 (fr) * 2003-06-19 2006-04-05 Meiji Seika Kaisha Ltd. Derive triazolobenzazepine tricyclique produit sous forme de nouvelle substance cristalline
WO2004113451A1 (fr) * 2003-06-20 2004-12-29 Meiji Seika Kaisha, Ltd. Produit de coprecipitation d'une substance peu soluble et d'un polymere soluble dans l'eau, et procede de production de celui-ci
DE602005003951T4 (de) 2004-05-14 2012-10-11 Millennium Pharmaceuticals, Inc. Verbindungen und verfahren zur inhibierung der mitotischen progression durch hemmung von aurorakinase
KR20080110760A (ko) * 2006-03-02 2008-12-19 메이지 세이카 가부시키가이샤 삼환성 트리아졸로벤즈아제핀 유도체를 포함하는 알레르기성 안질환 또는 알레르기성 비질환용 예방 또는 치료제
JP5588172B2 (ja) * 2006-09-25 2014-09-10 フォルシュングフェアブント ベルリン エー.ファウ. プロリンが豊富なペプチドの構造的模倣薬およびその医薬用途
CL2007003244A1 (es) 2006-11-16 2008-04-04 Millennium Pharm Inc Compuestos derivados de pirimido[5,4-d][2]benzazepina; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento del cancer.
KR101216756B1 (ko) * 2007-12-18 2012-12-28 메이지 세이카 파루마 가부시키가이샤 염증성 장질환의 예방 또는 치료제
US20100183601A1 (en) 2008-12-22 2010-07-22 Millennium Pharmaceuticals, Inc. Combination of Aurora Kinase Inhibitors and Anti-CD20 Antibodies
JO3635B1 (ar) 2009-05-18 2020-08-27 Millennium Pharm Inc مركبات صيدلانية صلبة وطرق لانتاجها
AU2010339691B2 (en) * 2010-01-07 2015-04-02 Alkermes Pharma Ireland Limited Prodrugs of heteraromatic compounds
US8653064B2 (en) 2010-02-19 2014-02-18 Millennium Pharmaceuticals, Inc. Crystalline forms of sodium 4-{[9-chloro-7-(2-fluoro-6-methoxyphenyl)-5H-pyrimido[5,4-D][2]benzazepin-2-yl]amino}-2-methoxybenzoate
US20130303519A1 (en) 2012-03-20 2013-11-14 Millennium Pharmaceuticals, Inc. Methods of treating cancer using aurora kinase inhibitors
JP6360881B2 (ja) 2013-03-22 2018-07-18 ミレニアム ファーマシューティカルズ, インコーポレイテッドMillennium Pharmaceuticals, Inc. 触媒的mtorc1/2阻害薬及びオーロラaキナーゼの選択的阻害薬の組合せ
JP2018524292A (ja) 2015-07-21 2018-08-30 ミレニアム ファーマシューティカルズ, インコーポレイテッドMillennium Pharmaceuticals, Inc. オーロラキナーゼインヒビターと化学療法剤の投与

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69427023T2 (de) * 1993-12-28 2001-10-31 Meiji Seika K.K., Tokio/Tokyo Tricyclische benzazepin-und benzothiazepin derivate
JP3537446B2 (ja) * 1995-06-15 2004-06-14 明治製菓株式会社 三環性ベンゾアゼピン化合物
KR19990087585A (ko) * 1996-03-08 1999-12-27 돈 리사 로얄 신경학적 활성제로서의 아졸로벤즈아제핀 유도체
US20070059533A1 (en) * 2005-09-12 2007-03-15 Burdette Steven R Thermal reflow of glass and fused silica body

Also Published As

Publication number Publication date
DE69811930T2 (de) 2003-12-18
TW510902B (en) 2002-11-21
IL135303A0 (en) 2001-05-20
US7022860B2 (en) 2006-04-04
CN1278262A (zh) 2000-12-27
EP1026167A1 (fr) 2000-08-09
KR100389140B1 (ko) 2003-06-25
PT1026167E (pt) 2003-07-31
WO1999016770A1 (fr) 1999-04-08
NZ503601A (en) 2002-02-01
NO319542B1 (no) 2005-08-29
CA2305307C (fr) 2004-11-30
KR20010030784A (ko) 2001-04-16
US20020137739A1 (en) 2002-09-26
TR200000808T2 (tr) 2000-08-21
RU2198885C2 (ru) 2003-02-20
ES2191963T3 (es) 2003-09-16
CN1312135C (zh) 2007-04-25
HUP0004020A3 (en) 2002-12-28
US6372735B1 (en) 2002-04-16
SK4252000A3 (en) 2000-10-09
NO20001500D0 (no) 2000-03-23
HK1032782A1 (en) 2002-08-30
BR9814055A (pt) 2000-09-26
ID24101A (id) 2000-07-06
EP1026167B1 (fr) 2003-03-05
CN1523019A (zh) 2004-08-25
DE69811930D1 (de) 2003-04-10
PL339544A1 (en) 2000-12-18
NO20001500L (no) 2000-05-18
CN1155599C (zh) 2004-06-30
CA2305307A1 (fr) 1999-04-08
US7238812B2 (en) 2007-07-03
BR9814055B1 (pt) 2009-05-05
US20060074074A1 (en) 2006-04-06
ATE233764T1 (de) 2003-03-15
AU9186998A (en) 1999-04-23
EP1026167A4 (fr) 2001-07-11
NO20043765L (no) 2000-05-18
AU744636B2 (en) 2002-02-28
SK283869B6 (sk) 2004-03-02
JP3188482B2 (ja) 2001-07-16
HUP0004020A2 (hu) 2001-09-28

Similar Documents

Publication Publication Date Title
DK1026167T3 (da) Tricykliske triazolobenzazepinderivater, fremgangsmåde til fremstilling af disse samt antiallergiske midler
PT733621E (pt) Novos derivados de imidazole e processo para a sua preparacao
ES2180477T3 (es) Compuestos intermedios para la preparacion de derivados de oxazolidindiona y tiazolidindiona.
DK0918776T3 (da) Totalsyntese af antitumor acylfulvener
DK0928788T3 (da) Imidazolidin-4-on-derivater, der er nyttige som anticancer-midler
ATE271045T1 (de) Sauerstoffhaltige heterocyclische verbindungen
AU3415599A (en) Benzoheterocyclic distamycin derivatives, process for preparing them, and their use as antitumor agents
EP1094055A4 (fr) Nouveaux derives vinylbenzene
NO940831L (no) Diiodforbindelser for anvendelse ved fremstilling av morfolinylderivater av doxorubicin, og deres fremstilling
BG102488A (en) Pesticidal compounds, compositions and methods for their preparation
HK1033455A1 (en) Novel tricyclic compounds, preparation method and pharmaceutical compositions containing same
AU7332996A (en) Therapeutics for thrombocytopenia
AR017971A1 (es) DERIVADOS TRICíCLICOS DE TRIAZOLBENZAZEPINAS, PROCEDIMIENTO PARA PRODUCIR LOS MISMOS, COMPOSICIONES FARMACEUTICAS FORMULADAS CON DICHOS COMPUESTOS Y COMPUESTOS INTERMEDIARIOS DE APLICACION EN DICHO PROCEDIMIENTO Y LA PEPARACION DE LOS MISMOS.
EP1072582A4 (fr) Composes intermediaires entrant dans la synthese de la fraction cyclique de derives 2-substitues de la vitamine d
EP1251129A4 (fr) Derives de la pyrimidine a effet anti-tumoral
MX9704976A (es) Derivados de 1,2,3-benzotiadiazol.